Pasar al contenido principal

PROCESOS MOLECULARES IMPLICADOS EN LA FORMACION DE LOS RIBOSOMAS HUMANOS

PID2020-118378GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SALAMANCA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma

  • Fernández-Parejo, Natalia
  • Lorenzo-Martín, L. Francisco
  • García-Pedrero, Juana María
  • Rodrigo, Juan P.
  • Dosil, Mercedes
  • Bustelo, Xosé R.
VAV2 is an activator of RHO GTPases that promotes and maintains regenerative proliferation-like states in normal keratinocytes and oral squamous cell carcinoma (OSCC) cells. Here, we demonstrate that VAV2 also regulates ribosome biogenesis in those cells, a program associated with poor prognosis of human papilloma virus-negative (HPV−) OSCC patients. Mechanistically, VAV2 regulates this process in a catalysis-dependent manner using a conserved pathway comprising the RAC1 and RHOA GTPases, the PAK and ROCK family kinases, and the c-MYC and YAP/TAZ transcription factors. This pathway directly promotes RNA polymerase I activity and synthesis of 47S pre-rRNA precursors. This process is further consolidated by the upregulation of ribosome biogenesis factors and the acquisition of the YAP/TAZ-dependent undifferentiated cell state. Finally, we show that RNA polymerase I is a therapeutic Achilles’ heel for both keratinocytes and OSCC patient-derived cells endowed with high VAV2 catalytic activity. Collectively, these findings highlight the therapeutic potential of modulating VAV2 and the ribosome biogenesis pathways in both preneoplastic and late progression stages of OSCC., We thank A. Abad and C. García-Macías for lab and pathology work, respectively. X.R.B.’s project leading to these results has received funding from Worldwide Cancer Research (14-1248), the Castilla-León government (CSI145P20, CLC-2017-01), grants cofounded by MCIN/AEI/https://doi.org/10.13039/501100011033/ plus the European Research Development Fund “A way of making Europe” of the European Union (PID2021-122666OB-I00), “la Caixa” Banking Foundation (HR20-00164), and the Programa Excelencia of the Fundación Científica AECC 2022 (EPAEC222641CICS). M.D.’s work has been supported by a grant cofounded by MCIN/AEI/https://doi.org/10.13039/501100011033/ plus the European Research Development Fund “A way of making Europe” of the European Union (PID2020-118378GB-I00). The authors’ institution was supported by the Programas de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Castilla-León government (CLC-2017-01 and CL-EI-2021-02) that were both cofounded by the European Research Development Fund. N.P. contract has been mostly supported by funding from the Spanish Ministry of Universities (FPU17/03912) and, subsequently, by the HR20-00164 grant (see above). L.F.L.-M. contract has been mostly supported by funding from the Spanish Ministry of Education, Culture and Sports (FPU13/02923) and, subsequently, by the CLC-2017-01 grant., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ribosomal protein deficiencies linked to Diamond-Blackfan anemia induce distinctive alterations of ATF4 expression

  • Lorenzo-Martín, L. Francisco
  • Robles-Valero, Javier
  • Ramírez-Cota, Rosa
  • Gaspar, Sonia G.
  • Fuentes, Pedro
  • Gentilella, Antonio
  • Bustelo, Xosé R.
  • Dosil, Mercedes
Ribosomal protein haploinsufficiency causes Diamond-Blackfan anemia (DBA) and other ribosomopathies. DBA has been linked to p53 activation and reduced GATA1 expression, but these mechanisms do not fully explain the disease. This study unveils that deficiencies in small (RPS) or large (RPL) ribosomal subunit proteins cause a p53-independent loss of ATF4, a master regulator of stress responses and erythropoiesis, by reducing the pool of actively translating ATF4 mRNAs. This defect is more pronounced in RPS deficiencies because the loss of 40S, but not 60S, subunits cause a destabilization of ATF4 transcripts. ATF4 downregulation occurs in early hematopoietic progenitors and correlates with the severity of erythroid differentiation defects in patients with DBA. It is also linked to the de-repression of fetal hemoglobin in erythroid cells, a frequent feature in patients with DBA. Our findings indicate that impaired ATF4 expression might be a primary contributor to DBA and explain the aggravated erythroid failure of RPS-mutant patients., M.D. research has been financed by grants BFU2017-88192-P and PID2020-118378GB-I00, both of them co-funded by MCIN/AEI/10.13039/501100011033/ plus the European Research Development Fund “A way of making Europe” of the European Union. X.R.B. has received funding from the Castilla-León government (CSI145P20, CSI018P23), grants co-funded by MCIN/AEI/10.13039/501100011033/ plus the European Research Development Fund “A way of making Europe” of the European Union (PID2021-122666OB-I00, PDC2022-133027-I00, PLEC2022-009217), “la Caixa” Banking Foundation (HR20-00164), and the Programa Excelencia of the Fundación Científica AECC 2022 (EPAEC222641CICS). J.R.-V. received funding from the Carlos III Health Institute (PI20/01724). M.D. and X.R.B. center was supported by the Programas de Apoyo a Planes Estratégicos de Investigación de Estructuras de Investigación de Excelencia of the Castilla-León government (CLC-2017-01 and CL-EI-2021-02) that were both co-funded by the European Research Development Fund., Peer reviewed